NCT00604812View on ClinicalTrials.gov

Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 17, 2007

Primary Completion Date

September 17, 2010

Study Completion Date

September 17, 2010

Conditions
Migraine Disorders
Interventions
DRUG

rizatriptan benzoate (5 mg)

A single dose of rizatriptan 5 mg administered on Day 1.

DRUG

rizatriptan benzoate (10 mg)

A single dose of rizatriptan 10 mg administered on Day 1.

DRUG

Rizatriptan 5 mg Placebo

A single dose of rizatriptan 5 mg placebo administered on Day 1.

DRUG

Rizatriptan 10 mg Placebo

A single dose of rizatriptan 10 mg placebo administered on Day 1.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00604812 - Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1) | Biotech Hunter | Biotech Hunter